Published in Drug Week, March 18th, 2011
"Among proposed treatment modalities for persons with medication refractory epilepsy are implantable devices that rapidly detect and abort seizures. Computational resources in these devices are limited and much effort is directed to improving...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.